Diabetes Flashcards
screening, lifestyle, comprehensive care, natural products, tx algorithms, non-insulins, insulin dosing and calc, BG monitoring, hypoglycemia management, acute care DM, key counseling points
risk factors for DM
physical inactivity
BMI >/= 25
race/ethnicity
PMH gestational
a1c >/=5.7
first degree relative
HDL <35, TG >250
BP >140/90
CVD or smoking hx
s/sx diabetes
3 P’s
polyuria
polydipsia
polyphagia
what a1c, FBG and PPG are considered pre-DM
a1c 5.7-6.5
FBG 100-125
PPG 140-199
what a1c, FBG and PPG are considered DM
a1c >/= 6.5
FBG >/= 126
PPG >/= 200
an a1c of 6% = average BG of ______
and an increase of 1% = an increase in average BG of_______________-
126mg/dL
1% : 28mg/dL
lifestyle modifications for DM
weight loss 5% +
carb counting
exercise 150+ min a week
smoking cessation
comprehensive care
microvascular complications
nephropathy
retinopathy
neuropathy
macrovascular complications
ASCVD, MI, CVD
CVA
PAD
ASA recommendation for DM
secondary prevention only, 81mg po qd
how often should patients get an eye exam in DM
q1-2 years
1 year is if they have retinopathy
what vaccines are recommended in DM
HBV
influenza
pneumococcal
how often should DM patients get foot exams
annually
HLD management in DM
which statin? what is the LDL goal?
> 40 yo w ASCVD – > high intensity
no ASCVD or <40 w ASCVD –> mod intensity
goal <55 w ASCVD
goal <70 without ASCVD
how often should eGFR and UAlb be monitored in DM
yearly
what medications are recommended for hyperalbuminuria in DM
ACEi, ARB, SGLT2i, finerenone
BP goal in DM
<130/80
BP management in DM
no albuminuria or CAD: thiazide, ACE, ARB, CCB
albuminuria or CAD: ACEi or ARB
first line for ASCVD or high risk patient (>55 w 2 RFs)
GLP1RA
SGLT2i
first line for HF concern
SGLT2i
first line for CKD concern
= eGFR ____
= Ualb____
eGFR </= 60
UAlb >30
SGLT2i if eGFR >20 then GLP1RA
rybelsus dosing
3mg po qd 30 min before breakfast x30d then increase to 7mg po qd, MDD 14mg
GLP1RAs with cardiorenal benefits
semaglutide SC, liraglutide, dulaglutide
SGLT2i with cardiorenal benefits
dapa empa canag
TZD example
pioglitazone
DPP4-i
drugs in class
-gliptins